Experience
Shionogi Pharmaceuticals
Apotex Inc.
Successfully represented Shionogi Pharmaceuticals in multiple ANDA challenges to Orange Book listed patents covering its Doribax® pharmaceutical product.
Shionogi Pharmaceuticals v. Apotex Inc., 3:15-cv-00668, D.N.J., Judges Goodman, Sheridan
Shionogi Pharmaceuticals v. Sandoz, Inc., 3:12-cv-07907, D.N.J., Judges Goodman, Hillman, Williams, Wolfson
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
Otsuka Pharmaceutical Co., Ltd.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Valeant Pharmaceuticals NA, LLC
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
Otsuka Pharmaceutical Co., Ltd.
Cephalon, Inc. v. Sun Pharmaceuticals Industries, Inc.
Cephalon, Inc.
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.